Introduction
Hyperphosphatemia is a common biochemical alteration in patients with renal failure, hypoparathyroidism, pseudohypoparathyroidism, metabolic acidosis, acromegaly, and tumor lysis syndrome 1) . Serum phosphate is elevated occasionally in patients with multiple myeloma.
However, hyperphosphatemia is rare in patients with multiple myeloma unless renal failure is present, and most cases of multiple myeloma that present with hyperphosphatemia are accompanied by significant reduction of renal function below 30 mL/min of glomerular filtration rate (GFR) 2, 3) . We report a case of pseudohyperphosphatemia from a patient with multiple myeloma whose serum phosphate was constantly elevated without any symptom or sign of hyperphosphatemia.
Case Report
A 69-year-old woman suffered from dyspnea on exertion for a week. Severe anemia (hemoglobin 5.8 g/ dL) and aortic stenoinsufficiency was revealed on her blood test and echocardiogram. She was admitted for evaluation of anemia. The albumin-globulin ratio was reversed on her blood chemistry test, and BenceJones proteinuria was detected by routine urinalysis.
The bone marrow biopsy and serum and urine protein electrophoreses were performed, and she was diagnosed as the immunoglobulin G (IgG) kappa type of multiple myeloma. The sequential investigation showed that the stage of multiple myeloma was IIIA. There were no skin lesions such as calcified nodules or eczema, and deep tendon reflexes were normal at both upper and lower extremities. Neither lytic bone lesion nor soft tissue calcification was found on her simple radiograms. Serum creatinine was 1.6 mg/dL, and estimated GFR calculated by the abbreviated Modification of Diet in Renal Disease (MDRD) study equ- The hyperphosphatemia was suspected to be spurious because intact parathyroid hormone was normal and estimated GFR was not remarkably decreased.
Therefore, we took a single blood sample from her, and split it into two. One of the samples was treated with 20% sulfosalicylate to remove the paraprotein, and the serum phosphate, calcium, and albumin concentrations were compared between the two samples. The phosphate level was decreased to 3.5 mg/dL in the deproteinized sample, but it was 10.5 mg/dL in the other (Table 2) . Finally, she was diagnosed as pseudohyperphosphatemia occurring due to the interference of serum paraprotein with phosphate measurement, and she stopped . Serum of a patient with multiple myeloma has falsely elevated absorbance because paraproteins react with ammonium molybdate to make the serum cloudy [5] [6] [7] [8] . The level of serum phosphate returns to normal when it is measured after deproteinization with sulfosalicylate [5] [6] [7] 9) . We searched the PubMed and Korean medical literature database (KMbase and KoreaMed) for similar case reports. Keyword search under pseudo " hyperphosphatemia and multiple myeloma was per " " " formed.
Eight case reports from PubMed and 2 case reports from Korean databases were found 1, 5-12) (Table 3) .
Han et al. reported that pseudohyperphosphatemia was identified in 6 of 67 (9%) patients with multiple myeloma 8) . Clinical characteristics of these cases are summarized in Table 3 In conclusion, pseudohyperphosphatemia should be considered when serum phosphate increases in a Kim et al.
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